PETNET Solutions operates the largest Positron Emission Tomography (PET) radiopharmaceutical production network with over 50 production and distribution centres worldwide that produce and distribute PET radiopharmaceuticals to hospitals, clinics, and research facilities for PET imaging.
In Australia, the state-of-the-art PET radiopharmaceutical production facility built in Sydney's south, consists of two Siemens cyclotrons which produce the short-lived radiopharmaceutical 18F FDG (fluorodeoxyglucose) used in PET scanning. The facility began production in November 2009.
As molecular imaging evolves, PETNET Solutions delivers products and services that expand the value of PET to providers, referring medical specialists and patients. PETNET Solutions is delivering, expanding, and advancing the science of molecular imaging.
Read the latest news from PETNET Solutions, or send us your email address to subscribe to PETNET Solutions' quarterly e-newsletter.